Evidence map›Paper›PMID 24867951›Full record

ArticleThe Journal of biological chemistry2014

Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth.

Naoko Kubo Birukawa, Kazuyuki Murase, Yasushi Sato, Akemi Kosaka, Akihiro Yoneda, Hiroki Nishita, Ryosuke Fujita, Miyuki Nishimura, Takafumi Ninomiya, Keiko Kajiwara and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Actin cytoskeletal dynamics in hepatic myofibroblasts and fibrosis.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis.Translational research : the journal of laboratory and clinical medicine · 2019
    Review
  9. The Expanding Role of MT1-MMP in Cancer Progression.Pharmaceuticals (Basel, Switzerland) · 2019
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Genetic and epigenetic regulation of intestinal fibrosis.United European gastroenterology journal · 2016
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Naoko Kubo BirukawaFrom the Department of Molecular Target Exploration.
Kazuyuki Murase4th Department of Internal Medicine, and.
Yasushi Sato4th Department of Internal Medicine, and.
Akemi KosakaFrom the Department of Molecular Target Exploration.
Akihiro YonedaFrom the Department of Molecular Target Exploration.
Hiroki NishitaFrom the Department of Molecular Target Exploration.
Ryosuke FujitaFrom the Department of Molecular Target Exploration.
Miyuki NishimuraFrom the Department of Molecular Target Exploration.
Takafumi NinomiyaDepartment of Basic Medical Science Department of Anatomy (1), Sapporo Medical University School of Medicine, 060-8556 Sapporo, Japan.
Keiko KajiwaraFrom the Department of Molecular Target Exploration, the Translational Research Group, Hokkaido Laboratory, Molecular Therapeutics Department, Corporate Business Development Division, Nitto Denko Corporation, Hokkaido, 001-0021 Sapporo, Japan, and.
Miyono MiyazakiFrom the Department of Molecular Target Exploration, the Translational Research Group, Hokkaido Laboratory, Molecular Therapeutics Department, Corporate Business Development Division, Nitto Denko Corporation, Hokkaido, 001-0021 Sapporo, Japan, and.
Yusuke NakashimaFrom the Department of Molecular Target Exploration.
Sigenori OtaFrom the Department of Molecular Target Exploration.
Yuya MurakamiFrom the Department of Molecular Target Exploration.
Yasunobu TanakaFrom the Department of Molecular Target Exploration, the Translational Research Group, Hokkaido Laboratory, Molecular Therapeutics Department, Corporate Business Development Division, Nitto Denko Corporation, Hokkaido, 001-0021 Sapporo, Japan, and.
Kenjiro MinomiFrom the Department of Molecular Target Exploration, the Translational Research Group, Hokkaido Laboratory, Molecular Therapeutics Department, Corporate Business Development Division, Nitto Denko Corporation, Hokkaido, 001-0021 Sapporo, Japan, and.
Yasuaki Tamurathe Faculty of Advanced Life Science, Hokkaido University, 001-0021 Sapporo, Japan.
Yoshiro NiitsuFrom the Department of Molecular Target Exploration, niitsu@sapmed.ac.jp.
Sapporo Medical University · JPNitto (Japan) · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stellate cells are distributed throughout organs, where, upon chronic damage, they become activated and proliferate to secrete collagen, which results in organ fibrosis. An intriguing property of hepatic stellate cells (HSCs) is that they undergo apoptosis when collagen is resolved by stopping tissue damage or by treatment, even though the mechanisms are unknown. Here we disclose the fact that HSCs, normal diploid cells, acquired dependence on collagen for their growth during the transition from quiescent to active states. The intramolecular RGD motifs of collagen were exposed by cleavage with their own membrane type 1 matrix metalloproteinase (MT1-MMP). The following evidence supports this conclusion. When rat activated HSCs (aHSCs) were transduced with siRNA against the collagen-specific chaperone gp46 to inhibit collagen secretion, the cells underwent autophagy followed by apoptosis. Concomitantly, the growth of aHSCs was suppressed, whereas that of quiescent HSCs was not. These in vitro results are compatible with the in vivo observation that apoptosis of aHSCs was induced in cirrhotic livers of rats treated with siRNAgp46. siRNA against MT1-MMP and addition of tissue inhibitor of metalloproteinase 2 (TIMP-2), which mainly inhibits MT1-MMP, also significantly suppressed the growth of aHSCs in vitro. The RGD inhibitors echistatin and GRGDS peptide and siRNA against the RGD receptor αVβ1 resulted in the inhibition of aHSCs growth. Transduction of siRNAs against gp46, αVβ1, and MT1-MMP to aHSCs inhibited the survival signal of PI3K/AKT/IκB. These results could provide novel antifibrosis strategies.

Indexed as

AnimalsApoptosisCell ProliferationCell SurvivalCollagenHepatic Stellate CellsHSP47 Heat-Shock ProteinsHumansI-kappa B ProteinsIntegrinsLiver CirrhosisMatrix Metalloproteinase 14Matrix Metalloproteinase InhibitorsMiceOligopeptidesPhosphatidylinositol 3-Kinasesarginyl-glycyl-aspartic acidCollagenHSP47 Heat-Shock ProteinsI-kappa B ProteinsIntegrinsMatrix Metalloproteinase 14Matrix Metalloproteinase InhibitorsOligopeptidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingSerpinh1 protein, ratTIMP1 protein, ratTissue Inhibitor of Metalloproteinase-1ApoptosisExtracellular MatrixFibrosisHeat Shock Protein (HSP)Integrin

Identifiers

PMID24867951
PMCPMC4106337
OpenAlexW2049049366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.